Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP302998.RACSk9mm0zES4HFePE7Uy243DbBlAhNzA7n2f42NEF1Hg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP302998.RACSk9mm0zES4HFePE7Uy243DbBlAhNzA7n2f42NEF1Hg130_assertion type Assertion NP302998.RACSk9mm0zES4HFePE7Uy243DbBlAhNzA7n2f42NEF1Hg130_head.
- NP302998.RACSk9mm0zES4HFePE7Uy243DbBlAhNzA7n2f42NEF1Hg130_assertion description "[This study provides important evidence for inhibition of hepatocellular carcinoma (HCC) growth by 15-PGDH through the 15-keto-prostaglandin E2 (15-keto-PGE2)/peroxisome proliferator-activated receptor-? (PPAR?)/p21(WAF1/Cip1) signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302998.RACSk9mm0zES4HFePE7Uy243DbBlAhNzA7n2f42NEF1Hg130_provenance.
- NP302998.RACSk9mm0zES4HFePE7Uy243DbBlAhNzA7n2f42NEF1Hg130_assertion evidence source_evidence_literature NP302998.RACSk9mm0zES4HFePE7Uy243DbBlAhNzA7n2f42NEF1Hg130_provenance.
- NP302998.RACSk9mm0zES4HFePE7Uy243DbBlAhNzA7n2f42NEF1Hg130_assertion SIO_000772 23542179 NP302998.RACSk9mm0zES4HFePE7Uy243DbBlAhNzA7n2f42NEF1Hg130_provenance.
- NP302998.RACSk9mm0zES4HFePE7Uy243DbBlAhNzA7n2f42NEF1Hg130_assertion wasDerivedFrom befree-20150227 NP302998.RACSk9mm0zES4HFePE7Uy243DbBlAhNzA7n2f42NEF1Hg130_provenance.
- NP302998.RACSk9mm0zES4HFePE7Uy243DbBlAhNzA7n2f42NEF1Hg130_assertion wasGeneratedBy ECO_0000203 NP302998.RACSk9mm0zES4HFePE7Uy243DbBlAhNzA7n2f42NEF1Hg130_provenance.